Related Experiment Videos
MUC1 expression in plasmacytoma
S Paydaş1, B Sahin, G Gönlüşen
1Department of Oncology, Faculty of Medicine, Cukurova University, 01330 Balcali, Adana, Turkey. sepay@mail.cu.edu.tr
Abstract:
Plasmacytoma (Pm) is a plasma cell (PC) neoplasia consisting of PCs and some of them show progression to multiple myeloma. But there is no clear indicators predicting this progression. In this study, MUC1 expression was evaluated in Pm cases to determine the predictive value and was compared with histopathologic grade which is known to be a prognostic indicator in Pm. Nine of 31 cases with Pm showed MUC1 expression. Only two of the 18 cases with mature morphology showed MUC1 expression while seven of 13 cases with immature morphology showed MUC1 expression and this was statistically significant (P<0.006). Additionally, four of 11 cases with BM involvement showed MUC1 expression while five of 20 cases without BM involvement showed MUC1 expression. There was a trend MUC1 expression with BM involvement but there was not statistically significant association between MUC1 expression and BM involvement. We found that MUC1 expression is associated with immature morphology which is an important prognostic indicator in Pm and by analogy MUC1 expression may be an additional prognostic indicator in patients with Pm.
Insights
MUC1 expression in plasmacytoma (Pm) correlates with immature cell morphology, a key prognostic indicator. This suggests MUC1 may serve as an additional predictive marker for Pm progression to multiple myeloma.
Area of Science:
- Hematology
- Oncology
- Molecular Pathology
Background:
- Plasmacytoma (Pm) is a plasma cell (PC) neoplasm with potential progression to multiple myeloma.
- Current indicators for predicting Pm progression are limited.
- Histopathologic grade is an established prognostic factor in Pm.
Purpose of the Study:
- To evaluate MUC1 expression in plasmacytoma cases.
- To determine the predictive value of MUC1 expression in Pm.
- To compare MUC1 expression with histopathologic grade and bone marrow (BM) involvement.
Main Methods:
- Retrospective analysis of 31 plasmacytoma cases.
- Assessment of MUC1 expression using immunohistochemistry.
- Correlation of MUC1 expression with histopathologic morphology (mature vs. immature) and bone marrow involvement.
Main Results:
- MUC1 expression was observed in 9 out of 31 Pm cases.
- MUC1 expression was significantly associated with immature morphology (7/13 cases) compared to mature morphology (2/18 cases) (P<0.006).
- A trend towards association between MUC1 expression and bone marrow involvement was noted, but it was not statistically significant.
Conclusions:
- MUC1 expression is significantly associated with immature morphology in plasmacytoma.
- Given the prognostic importance of immature morphology, MUC1 expression may serve as an additional prognostic indicator in Pm.
- Further research is warranted to confirm MUC1's role in predicting Pm progression to multiple myeloma.